Epitope Discovery via Nanocluster Presentation
Epitope Discovery via Nanocluster Presentation
批准号:
7783751
负责人:
DAVID E CLIFFEL
金额:
$29.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2012-02-28
关键词:
AntibodiesAntigensBiologyChildhoodCommunicable DiseasesDevelopmentDiagnosticEmerging Communicable DiseasesEngineeringEpitopesFaceFoundationsFutureGenerationsGoalsGoldHumanImmune systemImmunologistImmunotherapyInstitutesKnowledgeLabelLibrariesMedicineMethodsMolecular ConformationMusNanostructuresNanotechnologyPatientsPeptidesProteinsRecombinantsResearchResearch PersonnelScreening procedureSerumStructureSurfaceTechnologyToxinVaccinesWorkanthrax protective factorbasedesignimmunogeniclaboratory facilitymicroorganismmolecular recognitionnanobiotechnologynanomedicinenanoparticlenovelnovel strategiespathogenpeptide structureprotein structureresponsescaffoldsynthetic proteinvaccine candidate
中文摘要
该提案的目的是开发用于表位呈递的多功能纳米颗粒平台,
金纳米团簇与免疫分析,用于创建针对免疫的纳米技术
系统基于纳米颗粒的疫苗的未来发展需要产生蛋白质
忠实地再现病原微生物保护性抗原构象的结构。
具有讽刺意味的是,我们在逻辑上设计具有保护性的重组或合成蛋白质抗原的能力相当有限。
有限公司由于天然蛋白质上的大多数表位都可能被组装,因此最重要的表位之一
表位测定工作面临的挑战是构象组装表位的鉴定。
我们推测,在金纳米团簇表面呈现的靶蛋白环结构
将呈现潜在环构象的统计学显著多样性,以提供
发现致病毒素未知表位的新方法。为了证明这一点的可行性
通过这种方法,我们正在创造一种表位标记的纳米簇,它模拟了芽孢杆菌的保护性抗原(PA),
炭疽病在这个提议中,我们的目标是改进和扩展我们的表位概念策略,
通过以下具体目标介绍纳米团簇:
1.在金表面设计、合成和组装线性和构象表位
纳米团簇
2.确定哪种构象肽环构建体忠实地代表天然存在的
免疫原性结构。
3.使用纳米簇上呈递的表位筛选小鼠和人抗体文库以及患者血清
working加工towards走向the development发展of a diagnostic诊断microarray微阵列.
4.优化多功能纳米颗粒在小鼠体内的免疫应答。
纳米技术的具体挑战将是在纳米颗粒上创建特定的子结构
表面,这些特定构象的免疫识别,多功能纳米颗粒的产生,以及
肽环结构与纳米颗粒尺寸和曲率的关系。的具体变化
生物学和医学包括发现未定位的线性和构象表位,免疫表位,
系统对功能化纳米颗粒的响应,用于构象的抗体库的筛选,
表位,并最终发展到构象表位标记的纳米颗粒作为潜在的
疫苗。
英文摘要
The purpose of this proposal is to develop a multifunctional nanoparticle platform for epitope presentation on
gold nanoclusters with immunological analysis for the creation of nanotechnologies that target the immune
system. The future development of nanoparticle-based vaccines requires the generation of protein
structures that faithfully recapitulate the conformation of protective antigens of pathogenic microorganisms.
Ironically, our ability to logically design recombinant or synthetic protein antigens that are protective is quite
limited. As most epitopes on native proteins are likely to be assembled, one of the most significant
challenges facing epitope determination efforts is the identification of conformationally assembled epitopes.
We hypothesize that the presentation of target protein loop structures on the surface of gold nanoclusters
will present a statistically significant diversity of potential loop conformations to provide the foundation of a
new method for discovering unknown epitopes of pathogenic toxins. To demonstrate the feasibility of this
approach, we are creating an epitope-labeled nanocluster that mimics the protective antigen (PA) of Bacillus
anthracis. In this proposal, our goal is to refine and extend our conceptual strategies for epitope
presentation on nanoclusters via the following specific aims:
1. Design, synthesize, and assemble linear and conformational epitopes on the surface of gold
nanoclusters.
2. Determine which of the conformational peptide loop constructs faithfully represent the naturally occurring
immunogenic structures in native protein.
3. Screen mouse and human antibody libraries, and patient sera using epitopes presented on nanoclusters
working towardsthe development of a diagnostic microarray.
4. Optimize the immunological response of multifunctional nanoparticles in mice.
Specific challenges in nanotechnology will be the creation of specific substructures on a nanoparticle
surface, immunorecognition of these specific conformations, creation of multifunctional nanoparticles, and
correlation of peptide loop structure as a function of nanoparticle size and curvature. Specific changes in
biology and medicine include the discovery of unmapped linear and conformational epitopes, the immune
system response to functionalized nanoparticles, the screening of antibodies libraries for conformational
epitopes, and ultimate development towards conformational epitope-labeled nanoparticles as potential
vaccines.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s00216-010-4419-8
发表时间:
2011-01
期刊:
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
影响因子:
4.3
作者:
[Miller, Scott A., Hiatt, Leslie A., Keil, Robert G., Wright, David W., Cliffel, David E.]
通讯作者:
Cliffel, David E.
Potentiating Psilocybin
-
批准号:10354547
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2022
-
负责人:DAVID E CLIFFEL
-
依托单位:
Potentiating Psilocybin
-
批准号:10602394
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2022
-
负责人:DAVID E CLIFFEL
-
依托单位:
Instrumenting the Fetal Membrane on a Chip
-
批准号:10037372
-
项目类别:
-
资助金额:$66.29万
-
财政年份:2020
-
负责人:DAVID E CLIFFEL
-
依托单位:
Instrumenting the Fetal Membrane on a Chip
-
批准号:10651647
-
项目类别:
-
资助金额:$61.85万
-
财政年份:2020
-
负责人:DAVID E CLIFFEL
-
依托单位:
Instrumenting the Fetal Membrane on a Chip
-
批准号:10430227
-
项目类别:
-
资助金额:$63.11万
-
财政年份:2020
-
负责人:DAVID E CLIFFEL
-
依托单位:
Instrumenting the Fetal Membrane on a Chip
-
批准号:10249282
-
项目类别:
-
资助金额:$63.72万
-
财政年份:2020
-
负责人:DAVID E CLIFFEL
-
依托单位:
The Fisk-Vanderbilt Biomedical Bridge to the Doctorate
-
批准号:8575127
-
项目类别:
-
资助金额:$29.15万
-
财政年份:2013
-
负责人:DAVID E CLIFFEL
-
依托单位:
The Fisk-Vanderbilt Biomedical Bridge to the Doctorate
-
批准号:8734456
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2013
-
负责人:DAVID E CLIFFEL
-
依托单位:
The Fisk-Vanderbilt Biomedical Bridge to the Doctorate
-
批准号:8883627
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2013
-
负责人:DAVID E CLIFFEL
-
依托单位:
The Fisk-Vanderbilt Biomedical Bridge to the Doctorate
-
批准号:9274302
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2013
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7909868
-
项目类别:
-
资助金额:$1.24万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7026629
-
项目类别:
-
资助金额:$28.24万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7383845
-
项目类别:
-
资助金额:$27.57万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7582398
-
项目类别:
-
资助金额:$27.57万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7186717
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: